Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Research provides basic insights into how cancer cells survive

It is the membrane of cancer cells that is at the focus of the new research now showing a completely new way in which cancer cells can repair the damage that can otherwise kill them.

5 Jul 2021

Study unravels genetic markers involved in life’s momentous milestones

A team of Oxford researchers successfully identified hundreds of genetic markers that are involved in two of life’s most momentous milestones.

5 Jul 2021

World’s first cancer cell model helps modern cancer research and drug development

For many years, computer models have been standard tools in fundamental biomedical research.

5 Jul 2021

New method can improve the efficacy of promising treatment for recurrent glioblastoma

A promising treatment for melanoma and other types of cancers is neoadjuvant immune checkpoint blockade (ICB).

1 Jul 2021

Rapid, inexpensive technique helps search large DNA databases

Computer scientists are deploying RAMBO to help genomic researchers who at times wait for days for search results from large DNA databases.

30 Jun 2021

Deep machine learning adds to the knowledge of one million molecules’ bioactivity

The Structural Bioinformatics and Network Biology team at IRB Barcelona has developed a tool that predicts the biological activity of chemical compounds.

30 Jun 2021

New tool sheds light on enzymatic activity linked to blood cancers, heart disease

Scientists have provided a better understanding of a process in immune cells that could help explain why certain people develop cardiovascular disease.

28 Jun 2021

Higher density mediates receptor activation in immune cells

Researchers from the University of Southampton have discovered how tumor necrosis factor receptors, a crucial class of immune receptors, are activated.

28 Jun 2021

Mayo Clinic researchers examine potential new CAR-T cell treatment for multiple myeloma

Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma.

28 Jun 2021

WEHI partners with Boehringer Ingelheim to develop novel anti-cancer therapeutics

WEHI has partnered with Boehringer Ingelheim, a leading research-driven pharmaceutical company, in a collaboration to discover and develop anti-cancer therapeutics using a promising new technology called targeted protein degradation.

From Walter and Eliza Hall Institute of Medical Research (WEHI) 25 Jun 2021

New 3Cs multiplex approach enables the study of the effect of genetic changes

Dr Manual Kaulich’s team at Goethe University has developed a new 3Cs multiplex approach that permits the effect of genetic alterations in any two genes to be investigated simultaneously in cell cultures.

25 Jun 2021

Researchers identify key cells involved in childhood brain cancer

A new study coordinated by the University of Trento could have identified the cell of origin of medulloblastoma—a malignant tumor in children that affects the central nervous system. In this study, scientists have used organoids to replicate the tumor tissue, for the first time.

25 Jun 2021

Prevalent protein in the blood plays a vital role in human fertilization, infection resistance

Albumin activates a proton channel which allows sperm to penetrate and fertilize an egg and white blood cells to secrete large amounts of inflammatory mediators.

23 Jun 2021

Scientists explore the human gut to combat SARS-CoV-2 virus

Scientists have discovered that some commensal bacteria residing in the human gut release compounds that suppress the SARS-CoV-2 virus.

21 Jun 2021

Study sheds new light on age-related diseases

Researchers from Sanford Burnham Prebys have explored the intricacies of autophagy to get a better understanding of the process.

21 Jun 2021

New method to control the complex communication network of cells

A study has proposed a new method for developing novel drugs based on the suppression of tyrosine kinase enzymes.

21 Jun 2021

Genetically engineering NK cells can target and kill glioblastoma stem cells

Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling protein, which blocks NK cell activity.

18 Jun 2021

Cancer News and Research

Research provides basic insights into how cancer cells survive

Study unravels genetic markers involved in life’s momentous milestones

World’s first cancer cell model helps modern cancer research and drug development

New method can improve the efficacy of promising treatment for recurrent glioblastoma

Rapid, inexpensive technique helps search large DNA databases

Deep machine learning adds to the knowledge of one million molecules’ bioactivity

New tool sheds light on enzymatic activity linked to blood cancers, heart disease

Higher density mediates receptor activation in immune cells

Mayo Clinic researchers examine potential new CAR-T cell treatment for multiple myeloma

WEHI partners with Boehringer Ingelheim to develop novel anti-cancer therapeutics

New 3Cs multiplex approach enables the study of the effect of genetic changes

Researchers identify key cells involved in childhood brain cancer

Prevalent protein in the blood plays a vital role in human fertilization, infection resistance

Scientists explore the human gut to combat SARS-CoV-2 virus

Study sheds new light on age-related diseases

New method to control the complex communication network of cells

Genetically engineering NK cells can target and kill glioblastoma stem cells

Presence of certain stem cells correlates with non-genetic resistance mechanisms to cancer drugs

Natural killer cells target breast cancer using the body’s immune system

'Enabler cells' in tumors could promote cancer metastasis

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics